Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02715011 |
| Title | Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Janssen Research & Development, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Detroit | Michigan | United States | Details | |||
| New York | New York | United States | Details | |||
| Charlotte | North Carolina | United States | Details | |||
| Philadelphia | Pennsylvania | United States | Details | |||
| Pittsburgh | Pennsylvania | United States | Details | |||
| Nashville | Tennessee | United States | Details | |||
| Houston | Texas | United States | Details | |||
| Barcelona | Spain | Details | ||||
| Madrid | Spain | Details | ||||
| Sevilla | Spain | Details |